1. People with non-calcified pulmonary nodules confirmed on CT have their nodule(s) assessed for risk of malignancy.

2. People with solid pulmonary nodules have their nodules assessed by semi-automated volumetry in preference to manual diameter measurements where possible and appropriate (eg, for smaller nodules and for measuring doubling time, when growth not obvious).

3. Positron emission tomography (PET)-CT examinations undertaken for assessment of solid pulmonary nodules are reported using qualitative assessment with an ordinal scale to define fluorodeoxyglucose (FDG) uptake as absent, faint, moderate or intense, in relation to background lung tissue and mediastinal blood pool, to facilitate use of the Herder risk prediction model.

4. People with pulmonary nodules confirmed on CT are offered discharge, further surveillance, further work up or treatment according to BTS guidelines (see for specific recommendations).

5. People with pulmonary nodules considered for definitive treatment and suitable for surgical intervention are offered lobectomy with pathological confirmation of malignancy by frozen section, if not previously confirmed, or anatomical segmentectomy if unfit for lobectomy.

6. People with pulmonary nodules considered for definitive treatment but who decline or who are unsuitable for surgery are offered ablative non-surgical treatment where safe.

7. People with pulmonary nodules confirmed on CT are offered verbal and written information that allows them to make an informed choice about their management.